Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L I Gordon

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
American Journal of Surgery|September 1, 1984
Preoperative combination chemotherapy for advanced stage head and neck cancer. Promising early resultsM S Kies, B C Pecaro, L I Gordon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2020
Corrections to "A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma"A M Evens, K R Carson, J Kolesar, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 1, 1985
Analysis of complete responders after initial treatment with chemotherapy in head and neck cancerM S Kies, L I Gordon, W W Hauck, et al.
Leukemia|October 27, 2016
Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by <sup>90</sup>Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499M R Smith, F Hong, H Li, et al.
Free Radical Biology & Medicine|March 1, 1995
Sequential changes in serum iron and ferritin in patients undergoing high-dose chemotherapy and radiation with autologous bone marrow transplantation: possible implications for treatment related toxicityL I Gordon, S G Brown, M S Tallman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2013
A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphomaA M Evens, K R Carson, J Kolesar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1987
Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council StudyS T Rosen, A M Zimmer, R Goldman-Leikin, et al.
Science (New York, N.Y.)|March 16, 1979
Submarine thermal sprirngs on the galapagos riftJ B Corliss, J Dymond, L I Gordon, et al.
Bone Marrow Transplantation|January 31, 2006
Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantationS Singhal, L I Gordon, M S Tallman, et al.
Blood|March 7, 1998
BCL-2 expression correlates with lower proliferative activity in the intermediate- and high-grade non-Hodgkin's lymphomas: an Eastern Cooperative Oncology Group and Southwest Oncology Group cooperative laboratory studyJ N Winter, J Andersen, J C Reed, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
American Journal of Surgery|September 1, 1984
Preoperative combination chemotherapy for advanced stage head and neck cancer. Promising early resultsM S Kies, B C Pecaro, L I Gordon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2020
Corrections to "A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma"A M Evens, K R Carson, J Kolesar, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 1, 1985
Analysis of complete responders after initial treatment with chemotherapy in head and neck cancerM S Kies, L I Gordon, W W Hauck, et al.
Leukemia|October 27, 2016
Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by <sup>90</sup>Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499M R Smith, F Hong, H Li, et al.
Free Radical Biology & Medicine|March 1, 1995
Sequential changes in serum iron and ferritin in patients undergoing high-dose chemotherapy and radiation with autologous bone marrow transplantation: possible implications for treatment related toxicityL I Gordon, S G Brown, M S Tallman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2013
A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphomaA M Evens, K R Carson, J Kolesar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1987
Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council StudyS T Rosen, A M Zimmer, R Goldman-Leikin, et al.
Science (New York, N.Y.)|March 16, 1979
Submarine thermal sprirngs on the galapagos riftJ B Corliss, J Dymond, L I Gordon, et al.
Bone Marrow Transplantation|January 31, 2006
Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantationS Singhal, L I Gordon, M S Tallman, et al.
Blood|March 7, 1998
BCL-2 expression correlates with lower proliferative activity in the intermediate- and high-grade non-Hodgkin's lymphomas: an Eastern Cooperative Oncology Group and Southwest Oncology Group cooperative laboratory studyJ N Winter, J Andersen, J C Reed, et al.
Pageof 8